Analysis anywhere across the Retina
Message from Dr Tassos Georgiou
Welcome to Ophthalmos Research and Educational Institute. Our dedicated team provides the latest therapies in treating eye disorders. With our state of the art premises and leading Ophthalmology technology we provide world class eye care.
We are here for you.
Dr. Tassos Georgiou
Welcome to
Ophthalmos Research and Educational Institute
Welcome to Ophthalmos Research and Educational Institute. We are a centre devoted exclusively to Ophthalmology, with more than 50 people working at the clinic, in a modern facility and equipped with the latest technology. We are the only centre in Cyprus offering a range of specialist operations through GESY, such as retinal detachments, corneal transplants, glaucoma lasers and repair of complicated cataract operations. More than 70,000 new patients were examined at the clinic since it opened.
Through our dedicated team of specialist surgeons, nurses, optometrists, orthoptists, technicians, researches and other staff, we are committed to excellence in healthcare, research and medical education by alleviating human suffering from eye diseases.
Our research is driven by a desire and mission to find cures for blindness through discovery and innovations. We have discovered a ground-breaking patented therapy for the first cause of blindness that enables us to change how the world sees.
The Ophthalmos Research Team will publish soon the results of the European prospective, multicentre, randomised, double-blind study designed to assess the potential effects of omega-3 fatty acids supplementation in dry age-related macular degeneration and Stargardt disease.(MADEOS clinical trial NCT03297515). The results have been presented be at the annual meeting of The Association for Research in Vision and Ophthalmology, in Denver, Colorado , May 2022. Link: https://iovs.arvojournals.org/article.aspx?articleid=2779038
We have a collaboration with the Biobanking and Biomedical Research of the University of Cyprus to determine the genes responsible for eye diseases in Cyprus. Link www.biobank.cy
We are also committed to teaching the future Ophthalmologists by offering the Medical students experience in clinical Ophthalmology. The final year Medical Students from the European Medical School have their clinical placement in Ophthalmology at our Institute.
TREATMENTS
Cataract
Laser
Retina
Cornea
Glaucoma
Oculoplastic
Optometry
Orthoptic
RESEARCH AT THE INSTITUTE
The Ophthalmos Research & Education Institute won patient trust and established itself in the consciousness of the Cypriots as a credible and pioneering center. The Institute’s upward course has succeeded in creating significant positive impact not only for Cypriot patients but also for the world map of ophthalmology. The research work continues with clinical studies in Europe for Stargardt’s disease and Dry Macular Degeneration.
At the same time, the positive results of our research have been published in international scientific journals. A few examples of our latest publications: Ischemic Optic Neuropathy in the Investigative Ophthalmology & Visual Science Journal, Dry Macular Degeneration and aging retina in the British Medical Journal Ophthalmology, Glaucoma in the Experimental Eye Journal and Stargardt’s disease in the Investigative Ophthalmology & Visual Science Journal.
MEET OUR DOCTORS
Our Services
VIP - Check Up Service
Ophthalmos Eye Laser Centre offers a comprehensive check up service to patients who would like to have an in depth understanding of their ocular condition.
Testimonials
Testimonials for the patented therapy of Ophthalmos Institute
Contact us
Our equipment
We are the only centre in Cyprus offering the latest and most efficient ophthalmic therapies using the most advanced equipment available in the market today such as:
OUR NEWS
Published research paper : Kalogerou M et al. Omega-3 fatty acids promote neuroprotection, decreased apoptosis and reduced glial cell activation in the retina of a mouse model of OPA1-related autosomal dominant optic atrophy. Exp Eye Res. Feb. 2022
These findings by Ophthalmos Research team support the use of omega-3 polyunsaturated fatty acids as a therapy for autosomal dominant optic atrophy.
